News

J&J plans to file 10 potential blockbusters by 2019


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

J&J plans to file 10 potential blockbusters by 2019


Date: 21/05/2015


Johnson & Johnson says it plans to file 10 new molecular entities - each with the potential of pulling in sales in excess of $1 billion - and 40 line extensions of existing and new medicines by 2019.

Coupled with 14 new product launches since 2009, seven of which are already blockbusters or close to it, the firm says its robust portfolio and late-stage pipeline have placed it in good stead to achieve above-industry compound annual growth over the next four years.

For more click here

Source: Pharmatimes

© Catalyst Innovation Portal 2019